Contribution to the Valorization of Plants Used in the Management of Rheumatic Diseases in Burkina Faso

Abstract

Joint pain is a real public health problem. According to recent studies, it is increasingly common in sub-Saharan Africa and represents a cause of greater loss of working days than accidents, heart disease and infections. The aim of this study was to study the pharmacochemical and therapeutic evidence of ten (10) plants used in the management of joint pain by traditional health practitioners in Ouagadougou. We conducted a meta-analysis of the data from December 2018 to September 2019. The anti-inflammatory activity of the ten (10) plants retained the maximum consensus internationally. Trichilia emetica Vahl (35.25%), Guiera senegalensis J.F.G.mel. (31%), Calotropis procera (Ait) Ait.F. (28.29%) and Crescientia cujete L. (25.12%) had more than 25% internationally reliability for their effects on joint pain. The structural analogy between conventional drugs and the molecules found in these plants has been confirmed. Additional studies should be carried out in order to improve and secure the use of these plants, which represent a prominent option in the therapeutic offer. identified in Trichilia emetica Vahl, Guiera senegalensis J.F.G.mel., Calotropis procera (Ait) Ait.F. These observations strengthen scientific basis for the use of Trichilia emetica Vahl, Guiera senegalensis J.F.G.mel., Calotropis procera (Ait) Ait.F. and Crescientia cujete L. in inflammatory joint pain treatment. The subsequent evaluation of therapeutic equivalences will allow the devel-opment of plant-based phytomedicines, standardized in therapeutic equivalent of modern treatments per gram of dry plant material. Evaluation of QSAR of plant compounds as indolic alkaloids and modified triterpenic compounds with potent anti-inflammatory properties could give models for drug design and dis-covery in the area of new therapies development.